1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
Jiang, Y.; Arase, N.; Kohyama, M.; Hirayasu, K.; Suenaga, T.; Jin, H.; Matsumoto, M.; Shida, K.; Lanier, L.L.; Saito, T.; et al.
Transport of misfolded endoplasmic reticulum proteins to the cell surface by MHC class II molecules. Int. Immunol. 2013,
25, 235–246. [CrossRef]
Jin, H.; Arase, N.; Hirayasu, K.; Kohyama, M.; Suenaga, T.; Saito, F.; Tanimura, K.; Matsuoka, S.; Ebina, K.; Shi, K.; et al.
Autoantibodies to IgG/HLA class II complexes are associated with rheumatoid arthritis susceptibility. Proc. Natl. Acad. Sci. USA
2014, 111, 3787–3792. [CrossRef]
Hiwa, R.; Ohmura, K.; Arase, N.; Jin, H.; Hirayasu, K.; Kohyama, M.; Suenaga, T.; Saito, F.; Terao, C.; Atsumi, T.; et al.
Myeloperoxidase/HLA Class II Complexes Recognized by Autoantibodies in Microscopic Polyangiitis. Arthritis Rheumatol. 2017,
69, 2069–2080. [CrossRef] [PubMed]
Jin, H.; Kishida, K.; Arase, N.; Matsuoka, S.; Nakai, W.; Kohyama, M.; Suenaga, T.; Yamamoto, K.; Sasazuki, T.; Arase, H.
Abrogation of self-tolerance by misfolded self-antigens complexed with MHC class II molecules. Sci. Adv. 2022, 8, eabj9867.
[CrossRef]
Tsuji, H.; Ohmura, K.; Jin, H.; Naito, R.; Arase, N.; Kohyama, M.; Suenaga, T.; Sakakibara, S.; Kochi, Y.; Okada, Y.; et al.
Anti-Double-Stranded DNA Antibodies Recognize DNA Presented on HLA Class II Molecules of Systemic Lupus Erythematosus
Risk Alleles. Arthritis Rheumatol. 2022, 74, 105–111. [CrossRef] [PubMed]
Miyakis, S.; Lockshin, M.D.; Atsumi, T.; Branch, D.W.; Brey, R.L.; Cervera, R.; Derksen, R.H.W.M.; De Groot, P.G.; Koike, T.;
Meroni, P.L.; et al. International consensus statement on an update of the classification criteria for definite antiphospholipid
syndrome (APS). J. Thromb. Haemost. 2006, 4, 295–306. [CrossRef] [PubMed]
McNeil, H.P.; Simpson, R.J.; Chesterman, C.N.; Krilis, S.A. Anti-phospholipid antibodies are directed against a complex antigen
that includes a lipid-binding inhibitor of coagulation: b2-glycoprotein I (apolipoprotein H). Proc. Natl. Acad. Sci. USA 1990,
87, 4120–4124. [CrossRef] [PubMed]
Galli, M.; Barbui, T.; Zwaal, R.F.; Comfurius, P.; Bevers, E.M. Antiphospholipid antibodies: Involvement of protein cofactors.
Haematologica 1993, 78, 1–4.
Matsuura, E.; Igarashi, Y.; Yasuda, T.; Triplett, D.A.; Koike, T. Anticardiolipin antibodies recognize b2-glycoprotein I structure
altered by interacting with an oxygen modified solid phase surface. J. Exp. Med. 1994, 179, 457–462. [CrossRef]
Schwarzenbacher, R.; Zeth, K.; Diederichs, K.; Gries, A.; Kostner, G.M.; Laggner, P.; Prassl, R. Crystal structure of human
b2-glycoprotein I: Implications for phospholipid binding and the antiphospholipid syndrome. EMBO J. 1999, 18, 6228–6239.
[CrossRef]
Tanimura, K.; Jin, H.; Suenaga, T.; Morikami, S.; Arase, N.; Kishida, K.; Hirayasu, K.; Kohyama, M.; Ebina, Y.; Yasuda, S.; et al.
b2-Glycoprotein I/HLA class II complexes are novel autoantigens in antiphospholipid syndrome. Blood 2015, 125, 2835–2844.
[CrossRef]
Int. J. Mol. Sci. 2023, 24, 10958
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
13 of 13
Tanimura, K.; Saito, S.; Nakatsuka, M.; Nagamatsu, T.; Fujii, T.; Fukui, A.; Deguchi, M.; Sasagawa, Y.; Arase, N.; Arase, H.; et al.
The b2-Glycoprotein I/HLA-DR Complex as a Major Autoantibody Target in Obstetric Antiphospholipid Syndrome. Arthritis
Rheumatol. 2020, 72, 1882–1891. [CrossRef] [PubMed]
Soderberg, O.; Gullberg, M.; Jarvius, M.; Ridderstrale, K.; Leuchowius, K.J.; Jarvius, J.; Wester, K.; Hydbring, P.; Bahram, F.;
Larsson, L.G.; et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods
2006, 3, 995–1000. [CrossRef] [PubMed]
Ichikawa, K.; Khamashta, M.A.; Koike, T.; Matsuura, E.; Hughes, G.R. b2-Glycoprotein I reactivity of monoclonal anticardiolipin
antibodies from patients with the antiphospholipid syndrome. Arthritis Rheum. 1994, 37, 1453–1461. [CrossRef]
Stepan, H.; Hund, M.; Andraczek, T. Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia:
The Angiogenic-Placental Syndrome. Hypertension 2020, 75, 918–926. [CrossRef]
Wang, A.; Rana, S.; Karumanchi, S.A. Preeclampsia: The role of angiogenic factors in its pathogenesis. Physiology 2009, 24, 147–158.
[CrossRef] [PubMed]
Lamont, R.F. Infection in the prediction and antibiotics in the prevention of spontaneous preterm labour and preterm birth. BJOG
2003, 110 (Suppl. 2), 71–75. [CrossRef]
Lockwood, C.J. Predicting premature delivery—No easy task. N. Engl. J. Med. 2002, 346, 282–284. [CrossRef]
Arase, N.; Tanimura, K.; Jin, H.; Yamaoka, T.; Kishibe, M.; Nishioka, M.; Kiyohara, E.; Tani, M.; Matsuoka, S.; Ohmura, K.; et al.
Novel autoantibody against the b2-glycoprotein I/human leucocyte antigen-DR complex in patients with refractory cutaneous
ulcers. Br. J. Dermatol. 2018, 178, 272–275. [CrossRef] [PubMed]
Agar, C.; van Os, G.M.; Morgelin, M.; Sprenger, R.R.; Marquart, J.A.; Urbanus, R.T.; Derksen, R.H.; Meijers, J.C.; de Groot, P.G.
b2-glycoprotein I can exist in 2 conformations: Implications for our understanding of the antiphospholipid syndrome. Blood 2010,
116, 1336–1343. [CrossRef]
Atik, R.B.; Christiansen, O.B.; Elson, J.; Kolte, A.M.; Lewis, S.; Middeldorp, S.; Mcheik, S.; Peramo, B.; Quenby, S.; Nielsen, H.S.;
et al. ESHRE guideline: Recurrent pregnancy loss: An update in 2022. Hum. Reprod. Open. 2022, 2023, hoad002.
ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy. Obstet. Gynecol. 2018, 132, e44–e52. [CrossRef]
ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstet. Gynecol. 2019, 133, 1.
Ono, Y.; Wada, S.; Ota, H.; Fukushi, Y.; Tanimura, K.; Yoshino, O.; Arase, H.; Yamada, H. Anti-b2-glycoprotein I/HLA-DR
antibody in fertility. J. Reprod. Immunol. 2023, 158, 103955. [CrossRef]
Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: A
committee opinion. Fertil. Steril. 2020, 113, 533–535. [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual
author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to
people or property resulting from any ideas, methods, instructions or products referred to in the content.
...
論文の公開元へ
